News

Metropolis Healthcare Limited announced that its Nomination and Remuneration Committee approved the allotment of 66,312 equity shares at an exercise price of INR 2 each, aggregating to INR 1,32,624, against vested and exercised Restrictive Stock Units under the Metropolis -Restrictive Stock Unit Plan, 2020. The newly issued shares, with a par value of INR 2, have a distinctive number range of 20,73,87,569 to 20,74,53,880, and will rank pari-passu with existing shares, with 50% of the shares subject to a one-year lock-in period expiring on September 8, 2027.

Net profit of Metropolis Healthcare rose 25.77% to Rs 56.67 crore in the quarter ended June 2026 as against Rs 45.06 crore during the previous quarter ended June 2025. Sales rose 16.62% to Rs 450.22 crore in the quarter ended June 2026 as against Rs 386.06 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales450.22386.06 17 OPM %24.7023.25 - PBDT110.1292.08 20 PBT77.7161.23 27 NP56.6745.06 26 Powered by Capital Market - Live News

Metropolis Healthcare has allotted 18,700 equity shares under the Metropolis-Restrictive Stock Unit Plan, 2020. With this allotment, the paid up equity share capital has increased to 20,73,87,568 equity shares of Rs 2 each.

Metropolis Healthcare will hold a meeting of the Board of Directors of the Company on 4 August 2026.

Metropolis Healthcare announced that the 26th Annual General Meeting(AGM) of the company will be held on 18 August 2026.